Bulletin
Investor Alert

Moderna Inc.

NAS: MRNA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 23, 2020, 7:59 p.m.

/zigman2/quotes/205619834/composite

$

70.80

Change

+0.27 +0.38%

Volume

Volume 70,749

Quotes are delayed by 20 min

/zigman2/quotes/205619834/composite

Previous close

$ 70.84

$ 70.53

Change

-0.31 -0.44%

Day low

Day high

$68.80

$72.40

Open

52 week low

52 week high

$15.52

$95.21

Open

Insider Actions for Moderna Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
10/20/2020 Stéphane Bancel
Chief Executive Officer; Director
8,455   Disposition at $72.05 per share. 609,182
10/19/2020 Tal Zaks
Chief Medical Officer
200   Disposition at $73.81 per share. 14,762
10/19/2020 Tal Zaks
Chief Medical Officer
3,100   Disposition at $73.12 per share. 226,672
10/19/2020 Tal Zaks
Chief Medical Officer
6,005   Disposition at $71.92 per share. 431,879
10/19/2020 Tal Zaks
Chief Medical Officer
5,695   Disposition at $71.24 per share. 405,711
10/19/2020 Tal Zaks
Chief Medical Officer
10,000   Derivative/Non-derivative trans. at $19.15 per share. 191,500
10/19/2020 Tal Zaks
Chief Medical Officer
5,000   Derivative/Non-derivative trans. at $12.21 per share. 61,050
10/16/2020 Stéphane Bancel
Chief Executive Officer; Director
3,600   Disposition at $76.11 per share. 273,996
10/16/2020 Stéphane Bancel
Chief Executive Officer; Director
2,198   Disposition at $75.24 per share. 165,377
10/16/2020 Stéphane Bancel
Chief Executive Officer; Director
5,248   Disposition at $74.17 per share. 389,244
10/15/2020 Stéphane Bancel
Chief Executive Officer; Director
10,000   Disposition at $75.48 per share. 754,800
10/14/2020 Stéphane Bancel
Chief Executive Officer; Director
1,000   Gift at $0 per share. 0
10/14/2020 Stéphane Bancel
Chief Executive Officer; Director
9,000   Disposition at $79.81 per share. 718,290
10/13/2020 Stephen Hoge
President
100   Disposition at $80.39 per share. 8,039
10/13/2020 Stephen Hoge
President
700   Disposition at $79.47 per share. 55,629
10/13/2020 Stephen Hoge
President
2,600   Disposition at $78.4 per share. 203,840
10/13/2020 Stephen Hoge
President
1,400   Disposition at $77.82 per share. 108,948
10/13/2020 Stephen Hoge
President
10,200   Disposition at $75.78 per share. 772,956
10/13/2020 Stephen Hoge
President
10,000   Derivative/Non-derivative trans. at $0.99 per share. 9,900
10/12/2020 Stéphane Bancel
Chief Executive Officer; Director
8,219   Disposition at $73.61 per share. 605,000
10/12/2020 Stephen Hoge
President
1,256   Disposition at $75.38 per share. 94,677
10/12/2020 Stephen Hoge
President
2,735   Disposition at $74.49 per share. 203,730
10/12/2020 Stephen Hoge
President
1,009   Disposition at $73.21 per share. 73,868
10/12/2020 Tal Zaks
Chief Medical Officer
4,279   Disposition at $75.32 per share. 322,294
10/12/2020 Tal Zaks
Chief Medical Officer
7,421   Disposition at $74.5 per share. 552,864
10/12/2020 Tal Zaks
Chief Medical Officer
3,300   Disposition at $73.3 per share. 241,890
10/12/2020 Tal Zaks
Chief Medical Officer
10,000   Derivative/Non-derivative trans. at $19.15 per share. 191,500
10/12/2020 Tal Zaks
Chief Medical Officer
5,000   Derivative/Non-derivative trans. at $12.21 per share. 61,050
10/09/2020 Stéphane Bancel
Chief Executive Officer; Director
400   Disposition at $73.55 per share. 29,420
10/09/2020 Stéphane Bancel
Chief Executive Officer; Director
10,646   Disposition at $72.97 per share. 776,838
10/08/2020 Stéphane Bancel
Chief Executive Officer; Director
10,000   Disposition at $73.5 per share. 735,000
10/07/2020 Stéphane Bancel
Chief Executive Officer; Director
1,000   Gift at $0 per share. 0
10/07/2020 Stéphane Bancel
Chief Executive Officer; Director
9,000   Disposition at $71.23 per share. 641,070

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
40 Purchases
164 Sales
383,708
11,904,336
Last 6 months
86 Purchases
435 Sales
2,524,191
27,914,079
Last 12 months
99 Purchases
608 Sales
3,357,778
39,540,772

Officers and Executives

Mr. Stéphane Bancel
Chief Executive Officer & Director
Dr. Stephen Hoge
President
Mr. David W. Meline
Chief Financial Officer
Mr. Juan Andres
Chief Technical Operations & Quality Officer
Dr. Tal Zaks
Chief Medical Officer
Dr. Melanie Ivarsson
Chief Development Officer
Ms. Jacqueline Miller
Senior VP-Infectious Disease Development
Mr. Patrick Norman Bergstedt
SVP-Commercial Vaccines
Mr. Raymond C. Jordan
Chief Corporate Affairs Officer
Mr. John Lepore
Senior Vice President-Government Engagement
Mr. Marcello Damiani
Chief Digital & Operational Excellence Officer
Dr. Francois Nader
Director
Dr. Sandra J. Horning
Director
Ms. Elizabeth E. Tallett
Director
Dr. John D. Mendlein
Director
Ms. Jennifer Ling Lee
Chief Accounting Officer
Ms. Tracey Franklin
Chief Human Resources Officer
Ms. Lori M. Henderson
Secretary & General Counsel
Dr. Charbel Haber
Senior Vice President-Regulatory Affairs
Dr. Noubar B. Afeyan
Chairman
Mr. Paul L. Sagan
Independent Non-Executive Director
Mr. Israel Ruiz
Independent Non-Executive Director
Dr. Robert S. Langer
Independent Non-Executive Director
Mr. Stephen A. Berenson
Independent Non-Executive Director
Link to MarketWatch's Slice.